Discovery of potent and selective dual cholinesterases and β-secretase inhibitors in pomegranate as a treatment for Alzheimer’s disease-Reference-Cited by-同舟云学术

Discovery of potent and selective dual cholinesterases and β-secretase inhibitors in pomegranate as a treatment for Alzheimer’s disease

Published:2022-12 Issue: Volume:129 Page:106137
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Yousof Ali Md.,Zaib Sumera,Jannat Susoma,Khan Imtiaz

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference59 articles.

1. Alzheimer’s Association. Alzheimer’s disease facts and figures, Alzheimers Dement. 8 (2012) 131–168.

2. C. Patterson, World Alzheimer report 2018. In: the state of the art of dementia research: new frontiers. Alzheimer’s Disease International. Alzheimer’s Disease International (ADI), London, UK, 2018, 32–36.

3. Alzheimer’s Disease International. World Alzheimer Report 2015. https://www. alz.co.uk/research/WorldAlzheimerReport2015.pdf.

4. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics;Hardy;Science,2002

5. Cholinergic function and Alzheimer’s disease;Giacobini;Int. J. Geriatr. Psychiatry,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring potential inhibitors of acetylcholinesterase, lactate dehydrogenases, and glutathione reductase from Hagenia abyssinica (Bruce) J.F. Gmel. based on multi-target ultrafiltration-liquid chromatography-mass spectrometry and molecular docking;Journal of Ethnopharmacology;2024-10

2. Pomegranate (Punica granatum L.) Extract Effects on Inflammaging;Molecules;2024-09-03

3. Phytochemical properties and bioactive compounds of pomegranate ( Punica granatum L.);The Journal of Horticultural Science and Biotechnology;2024-06-25

4. Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases;International Journal of Biological Macromolecules;2024-06

5. Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer’s disease: Synthesis, biochemical and in silico analyses;Bioorganic Chemistry;2023-12